Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with ...

A new discovery could pave the way for more effective cancer treatment by helping certain drugs work better inside the body.

RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...

An artificial intelligence (AI)-based model accurately classified pediatric sarcomas using digital pathology images alone, ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

Prostate cancer has distinct genetic properties in different groups of men that could be targeted to improve patient outcomes, new research suggests.

The new drug design deliveries up to 22 times more of he drug inside cancer cells, and tumor suppression ... and professor in the Department of Pathology at Duke University School of Medicine.

An artificial intelligence (AI)-based model developed by UT Southwestern Medical Center researchers can accurately predict ...

US FDA grants breakthrough device designation to Roche’s companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer: Basel Wednesday, April 30, 20 ...